US Worldmeds LLC

FDA Regulatory Profile

US Worldmeds LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1275-2019, Class II) was initiated on April 25, 2019.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1275-2019Class IIRevonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For April 25, 2019